Varisolve (Polidocanol Endovenous Microfoam)

Small molecule

Varisolve (Polidocanol Endovenous Microfoam) is one of 5 small molecule programs targeting Varicose veins. It is currently in development.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Varicose VeinsActive, not recruiting

Varicose VeinsPhase 2/Phase 3

Active, not recruiting

Competition

Competitive Landscape

12 competitors in Varicose Veins

#DrugCompanyPhaseTrials

Heparin Sodium

BBaxter Healthcare Corporation

Approved

—2

Calcium Dobesilate

GGuizhou Bailing Group Pharmaceutical Co Ltd

Approved

1 3

Sotradecol

HHelsinn Therapeutics (U.S.), Inc

Phase 1

1 4

Polidocanol Foam Sclerotherapy

HHospital Universitario Pedro Ernesto

Preclinical

1 5

Varisolve (Polidocanol Endovenous Microfoam)

BBoston Scientific Corporation

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Varicose veins1 trial

Randomized, Single Blind, Placebo Controlled, to Evaluate Efficacy and Safety of Polidocanol Injectable Foam for Treatment of Symptomatic, Visible Varicose Veins With SFJ Incompetence

Completed·BBoston Scientific Corporation·Phase 2/3·NCT00758420·77 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Varisolve (Polidocanol Endovenous Microfoam). U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Varisolve (Polidocanol Endovenous Microfoam) compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Varisolve (Polidocanol Endovenous Microfoam). EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Boston Scientific Corporation company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Company: BBoston Scientific Corporation

Varisolve (Polidocanol Endovenous Microfoam)

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Varicose veins1 trial

References

Drug Info

Quick Facts

Related News